Navigation Links
Research-based Pharmaceutical Industry and International Federation of Red Cross and Red Crescent Societies Join Forces to Prevent Non-Communicable Diseases

GENEVA, March 19, 2013 /PRNewswire/ --

  • Partnership is a novel cross-sector collaboration, responding to the United Nations call to tackle non-communicable diseases (NCDs)
  • Initiative goes beyond awareness-raising campaigns by prompting behavioral changes
  • Strategically combining expertise from pharmaceutical and humanitarian sectors, this initiative is expected to reach three million people

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) and the International Federation of Red Cross and Red Crescent Societies (IFRC) announced today a partnership on NCD prevention. The two-year partnership involves support from both organizations to design a behavioral change-based toolkit that promotes healthy lifestyle choices at national and community levels. Through its volunteer network and community-based expertise, the IFRC will make the toolkit available to approximately 3 million people worldwide.

The four main NCDs- cardiovascular diseases, cancer, chronic respiratory diseases and diabetes - kill three in five people worldwide, with 80 percent of NCD-related deaths occurring in low- and middle-income countries.

Because 50 percent of NCDs are avoidable, the IFPMA-IFRC partnership enhances efforts by both organizations to combat NCDs worldwide and support IFRC community interventions to reduce the impact of these diseases locally. Since releasing its Framework for Action on NCDs in 2011, IFPMA has delivered a series of research projects and health education initiatives to identify new ways to help people fight NCDs.

"By leveraging IFRC's and IFPMA's shared goal of fighting NCDs, this novel partnership brings synergy and creativity to fighting these diseases globally," says Eduardo Pisani , IFPMA Director General.

One of IFRC's core strengths lies in community volunteers' ability to tackle the underlying social, behavioral and environmental factors that determine good health through their on-the-ground work. "Changing behaviors by eliminating shared risk factors can save lives. Red Cross Red Crescent volunteers, going door-to-door in their communities play a vital role in promoting healthy lifestyles," says Bekele Geleta , IFRC Secretary General. "But no one single player from the public or private sector working in silo can tackle the NCDs challenges. Fighting NCDs requires multi-stakeholders solutions."

About the IFPMA:

IFPMA represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 1.3 million employees research, develop and provide medicines and vaccines that improve the life of patients worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.

SOURCE The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
2. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
3. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
4. Sagent Pharmaceuticals Selects ProspectoRx and Clinical Pharmacology
5. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.
6. Salix Pharmaceuticals Commits $1.125M to AGA Research Foundation
7. Peter W. Schineller Joins Alexza Pharmaceuticals as Senior Vice President and Chief Commercial Officer
8. Keryx Biopharmaceuticals Announces Appointment of Amit Sharma, M.D. as Vice President, Medical Affairs
9. Imprimis Pharmaceuticals Announces Underwriter Exercise of Over-Allotment Option
10. Isis Pharmaceuticals Reports Clinical Data Showing Blunting of Severe Increases in CRP Following Endotoxin Challenge With ISIS-CRP Rx
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
Breaking Medicine News(10 mins):